ATXS
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Astria Therapeutics announces final positive results from all enrolled HAE patients in ALPHA-STAR Phase 1b/2 trial of NavenibartNov 6, 2025
- Astria Therapeutics initiates Phase 3 ORBIT-EXPANSE long-term trial of Navenibart in people with hereditary angioedemaOct 8, 2025
- Astria Therapeutics begins enrolling HAE patients in EU for Phase 3 ALPHA-ORBIT trialOct 2, 2025
- Astria Therapeutics announces positive initial results from Phase 1a healthy subject trial of STAR-0310 at the European Academy of Dermatology and VenereologySep 17, 2025
- Astria Therapeutics to present initial data from Phase 1a trial of STAR-0310 at upcoming European Academy of Dermatology & Venereology Congress 2025Sep 3, 2025